VCEL
Vericel Corp Ord
NASDAQ: VCEL · HEALTHCARE · BIOTECHNOLOGY
$34.73
+3.89% today
Updated 2026-04-30
Market cap
$1.82B
P/E ratio
111.41
P/S ratio
6.57x
EPS (TTM)
$0.32
Dividend yield
—
52W range
$29 – $46
Volume
0.6M
Vericel Corp Ord (VCEL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
5.98%
Operating margin
24.10%
ROE
5.11%
ROA
1.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $863000.00 | $-16.48M | 98.73% | -2,054.81% | -1,909.04% |
| 2007 | $685000.00 | $-17.59M | 95.77% | -2,842.19% | -2,568.47% |
| 2008 | $522000.00 | $-20.13M | 89.27% | -4,064.94% | -3,856.90% |
| 2009 | $182000.00 | $-15.95M | 38.46% | -8,884.07% | -8,761.54% |
| 2010 | $89000.00 | $-17.73M | 61.80% | -20,004.49% | -19,920.22% |
| 2011 | $18000.00 | $-19.67M | 77.78% | -161,333.33% | -109,266.67% |
| 2012 | $21000.00 | $-29.47M | 71.43% | -160,761.90% | -140,352.38% |
| 2013 | $19000.00 | $-15.62M | 78.95% | -110,336.84% | -82,221.05% |
| 2014 | $28.80M | $-19.92M | 39.95% | -81.73% | -69.18% |
| 2015 | $51.17M | $-16.34M | 48.27% | -32.58% | -31.93% |
| 2016 | $54.38M | $-19.57M | 47.95% | -35.39% | -35.98% |
| 2017 | $63.92M | $-17.29M | 52.52% | -23.44% | -27.04% |
| 2018 | $90.86M | $-8.14M | 64.60% | -4.30% | -8.96% |
| 2019 | $117.85M | $-9.66M | 68.12% | -9.55% | -8.20% |
| 2020 | $124.18M | $2.86M | 67.83% | 1.91% | 2.31% |
| 2021 | $156.18M | $-7.47M | 67.88% | -5.03% | -4.78% |
| 2022 | $164.37M | $-16.71M | 66.80% | -10.38% | -10.17% |
| 2023 | $197.52M | $-3.18M | 68.64% | -3.27% | -1.61% |
| 2024 | $237.22M | $10.36M | 72.55% | 1.90% | 4.37% |
| 2025 | $276.26M | $16.52M | 74.42% | 4.00% | 5.98% |